Return to homepagePandemic Pact

to evaluate the efficacy of a single dose of azithromycin in the treatment of outpatient COVID-19 to prevent progression to hospitalization and severe disease.

Grant number: INV-017026

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2020

  • Known Financial Commitments (USD)

    $557,040

  • Funder

    Gates Foundation

  • Research Location

    United States of America

  • Lead Research Institution

    University of California San Francisco

  • Research Priority Alignment

    N/A

  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Supportive care, processes of care and management

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

N/A

2 Publications linked via Europe PMC

Last Updated:4 days ago

View all publications at Europe PMC

Qualitative evaluation to improve participant engagement and retention in remote COVID-19 treatment trials.

COVID-19 Related Shifts in Social Interaction, Connection, and Cohesion Impact Psychosocial Health: Longitudinal Qualitative Findings from COVID-19 Treatment Trial Engaged Participants.